Increased MUC4 expression was significantly correlated with prolonged survival time in breast cancer, colorectal cancer, and kidney renal cell carcinoma, while it was associated with poor survival in ovarian cancer, brain cancer, lung cancer, pancreatic cancer, thymoma, bladder carcinoma. Here, MUC4 is linked to colorectal cancer.